Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, R.
Right arrow Articles by Hazen, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, R.
Right arrow Articles by Hazen, S. L.
Related Collections
Right arrow Phagocytes
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 March 2002, Vol. 99, No. 5, pp. 1802-1810

PHAGOCYTES

Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma

Renliang Zhang, Zhongzhou Shen, William M. Nauseef, and Stanley L. Hazen

From the Department of Cell Biology, the Department of Cardiology, and the Center for Cardiovascular Diagnostics, Preventive Cardiology Section, Cleveland Clinic Foundation, OH; the Chemistry Department, Cleveland State University, OH; and the Inflammation Program and Department of Medicine, University of Iowa and Veterans Administration Medical Center, Iowa City.

More than a decade ago it was demonstrated that neutrophil activation in plasma results in the time-dependent formation of lipid hydroperoxides through an unknown, ascorbate-sensitive pathway. It is now shown that the mechanism involves myeloperoxidase (MPO)-dependent use of multiple low-molecular-weight substrates in plasma, generating diffusible oxidant species. Addition of activated human neutrophils (from healthy subjects) to plasma (50%, vol/vol) resulted in the peroxidation of endogenous plasma lipids by catalase-, heme poison-, and ascorbate-sensitive pathways, as assessed by high-performance liquid chromatography (HPLC) with on-line electrospray ionization tandem mass spectrometric analysis of free and lipid-bound 9-HETE and 9-HODE. In marked contrast, neutrophils isolated from multiple subjects with MPO deficiency failed to initiate peroxidation of plasma lipids, but they did so after supplementation with isolated human MPO. MPO-dependent use of a low-molecular-weight substrate(s) in plasma for initiating lipid peroxidation was illustrated by demonstrating that the filtrate of plasma (10-kd MWt cutoff) could supply components required for low-density lipoprotein lipid peroxidation in the presence of MPO and H2O2. Subsequent HPLC fractionation of plasma filtrate (10-kd MWt cutoff) by sequential column chromatography identified nitrite, tyrosine, and thiocyanate as major endogenous substrates and 17beta -estradiol as a novel minor endogenous substrate in plasma for MPO in promoting peroxidation of plasma lipids. These results strongly suggest that the MPO-H2O2 system of human leukocytes serves as a physiological mechanism for initiating lipid peroxidation in vivo.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. J. Nicholls and S. L. Hazen
Myeloperoxidase, modified lipoproteins, and atherogenesis
J. Lipid Res., April 1, 2009; 50(Supplement): S346 - S351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Erridge, S. Kennedy, C. M. Spickett, and D. J. Webb
Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION
J. Biol. Chem., September 5, 2008; 283(36): 24748 - 24759.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. E. Broderick, P. Potluri, S. Zhuang, I. E. Scheffler, V. S. Sharma, R. B. Pilz, and G. R. Boss
Cyanide Detoxification by the Cobalamin Precursor Cobinamide.
Experimental Biology and Medicine, May 1, 2006; 231(5): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Bluml, S. Kirchberger, V. N. Bochkov, G. Kronke, K. Stuhlmeier, O. Majdic, G. J. Zlabinger, W. Knapp, B. R. Binder, J. Stockl, et al.
Oxidized Phospholipids Negatively Regulate Dendritic Cell Maturation Induced by TLRs and CD40
J. Immunol., July 1, 2005; 175(1): 501 - 508.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. J. Nicholls and S. L. Hazen
Myeloperoxidase and Cardiovascular Disease
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1102 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. L. Hazen
Myeloperoxidase and Plaque Vulnerability
Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1143 - 1146.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Sugiyama, K. Kugiyama, M. Aikawa, S. Nakamura, H. Ogawa, and P. Libby
Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression: Involvement of Myeloperoxidase-Mediated Oxidant in Plaque Erosion and Thrombogenesis
Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1309 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y. Hasuike, T. Nakanishi, R. Moriguchi, Y. Otaki, M. Nanami, Y. Hama, M. Naka, K. Miyagawa, M. Izumi, and Y. Takamitsu
Accumulation of cyanide and thiocyanate in haemodialysis patients
Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1474 - 1479.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. POLIAKOV, M.-L. BRENNAN, J. MACPHERSON, R. ZHANG, W. SHA, L. NARINE, R. G. SALOMON, and S. L. HAZEN
Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo
FASEB J, December 1, 2003; 17(15): 2209 - 2220.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Shishehbor, M.-L. Brennan, R. J. Aviles, X. Fu, M. S. Penn, D. L. Sprecher, and S. L. Hazen
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Circulation, July 29, 2003; 108(4): 426 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Zhang, M.-L. Brennan, Z. Shen, J. C. MacPherson, D. Schmitt, C. E. Molenda, and S. L. Hazen
Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of Inflammation
J. Biol. Chem., November 22, 2002; 277(48): 46116 - 46122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. Brennan, W. Wu, X. Fu, Z. Shen, W. Song, H. Frost, C. Vadseth, L. Narine, E. Lenkiewicz, M. T. Borchers, et al.
A Tale of Two Controversies. DEFINING BOTH THE ROLE OF PEROXIDASES IN NITROTYROSINE FORMATION IN VIVO USING EOSINOPHIL PEROXIDASE AND MYELOPEROXIDASE-DEFICIENT MICE, AND THE NATURE OF PEROXIDASE-GENERATED REACTIVE NITROGEN SPECIES
J. Biol. Chem., May 10, 2002; 277(20): 17415 - 17427.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020